This compound is a pharmaceutical reference standard intermediate, characterized as a pyridine-carboxamide derivative bearing chloro, trifluoromethyl, and ether-linked aromatic substructures. It is used in analytical and manufacturing quality control processes within the pharmaceutical supply chain.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1431697-81-2
Sorafenib
Multikinase inhibitor for cancer research
Sorafenib tosylate
pharmaceutical raw material
1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride
pharmaceutical intermediate
(3R,5R)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester
pharmaceutical intermediate
(R)-5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole
pharmaceutical intermediate
Fmoc-D-Aph(tBuCbm)-OH
pharmaceutical intermediate
Regorafenib
pharmaceutical raw material
Regorafenib monohydrate
pharmaceutical raw material
4-[4-[[2-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
JWAKXXCHFJSKRN-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=CC(=C3Cl)C(F)(F)F